Skip to main content
VUNO, Inc. logo

VUNO, Inc. — Investor Relations & Filings

Ticker · 338220 ISIN · KR7338220007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 257 across all filing types
Latest filing 2022-04-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 338220

About VUNO, Inc.

https://www.vuno.co/

VUNO, Inc. is a medical artificial intelligence (AI) company that develops and provides a suite of AI-powered solutions designed to assist healthcare professionals. The company's technology analyzes a wide range of medical data, including medical imaging (CT, MRI, X-ray), digital pathology, and biosignals such as vital signs and ECG. Its product portfolio, marketed under the VUNO Med brand, offers clinical decision support tools for various medical specialties. Key solutions include VUNO Med-DeepCARS for predicting in-hospital cardiac arrest, VUNO Med-DeepBrain for quantitative analysis of brain atrophy in neurodegenerative diseases, and VUNO Med-Chest X-ray for detecting abnormalities in radiographs. The company aims to enhance diagnostic accuracy, improve clinical workflow efficiency, and contribute to better patient outcomes by integrating AI into routine medical practice.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including reasons such as stock option exercises and changes in board/management status. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-04-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes). Therefore, it is classified as a general regulatory filing.
2022-04-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of insider shareholdings and transactions, which corresponds to the 'Director's Dealing' category in the provided taxonomy.
2022-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by executives or major shareholders to disclose changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2022-04-07 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of an outside director (사외이사). This type of disclosure specifically concerns changes in the composition of the board of directors, which falls under the 'Board/Management Information' category.
2022-04-01 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by the company VUNO. It details the contract value, the counterparty (National IT Industry Promotion Agency), the contract period, and the nature of the supply (AI medical solutions). Since this is a specific regulatory disclosure regarding a material business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-04-01 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.